Digital Therapeutic Market - A Global and Regional Analysis: Analysis and Forecast, 2023-2033

Description

The digital therapeutic market report constitutes an extensive study of the digital therapeutics industry. Digital therapeutics (DTx) refers to evidence-based therapeutic interventions that use digital technologies to deliver medical treatments, interventions, and support for the prevention, management, or treatment of various medical conditions. These digital interventions are designed to improve health outcomes and can be used as standalone treatments or in conjunction with traditional medical therapies.

The key segments are:

By Product
- Software
- Devices

By Application
- Treatment/ Patient Care-related Application
  - Diabetes
  - Neurological Disorder
  - Smoking Cessation
  - Chronic Respiratory Disorders
  - Gastrointestinal Disorder
  - Cardiovascular Diseases
  - Medication Adherence
  - Rehabilitation & Patient Care
  - Others
- Preventive Applications
  - Nutrition Management
  - Lifestyle Management
  - Other

By Sales Channel
- Business-to-Business (B2B)
  - Insurance Providers
  - Corporate Employers
  - Pharmaceutical Companies
  - Others
- Business-to-Consumers
  - Patients
  - Caregivers

The digital therapeutic market is segregated into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Data for each of these regions, along with country-level analysis is provided in the market study.

The key market players in the digital therapeutic market are: Akili Interactive Labs, Inc., HiDoc Technologies GmbH (Cara Care), Click Therapeutics, Inc., ResMed, and 2MORROW, Inc., Omada Health, Inc. among others.

Product Definition

According to BIS Research, the digital therapeutic market, often referred to as "DTx" or "digital therapeutics," is a rapidly growing sector within the healthcare industry. Digital therapeutics are evidence-based therapeutic interventions that use digital technologies, such as mobile apps, software programs, wearable devices, and telehealth solutions, to deliver medical treatments and interventions for various medical conditions and health challenges.

How can this report add value?

The digital therapeutic market presents a valuable opportunity for organizations to diversify their healthcare offerings and enhance their value proposition. By incorporating evidence-based digital therapeutics into their portfolios, healthcare providers, pharmaceutical companies, and insurers can improve patient outcomes and increase patient engagement.

The Digital Therapeutic Market Report is a concise analysis of the rapidly growing market including a snapshot of the current market landscape, covering key trends, opportunities, and challenges. The report also highlights different products, applications, and sales channels of the market such as software and devices. Additionally, the report profiles leading companies and startups in the market, offering insights into their strategies and innovations. With a focus on market size, growth projections, and regional dynamics, the digital therapeutic market report is a valuable resource for manufacturers, distributors, and other pharmaceutical companies.

1. Global Digital Therapeutic Market: Overview

1.1. Product Definition
1.2. Inclusion and Exclusion Criteria
1.3. Key Findings

2. Global Digital Therapeutic Market: Industry Analysis

2.1. Key Trends
2.2. Value Chain Analysis
2.3. Funding Scenario
2.4. Regulatory Framework
2.5. Patent Analysis

3. Global Digital Therapeutic Market: Market Dynamics

3.1. Impact Analysis
3.2. Market Drivers
3.3. Market Restraints
3.4. Market Opportunities

4. Global Digital Therapeutic Market (by Product)

4.1. Overview
4.2. Growth Share Matrix
4.3. Software
4.4. Devices

5. Global Digital Therapeutic Market (by Application)

5.1. Overview
5.2. Growth Share Matrix
5.3. Treatment/ Patient Care-related Application
- 5.3.1. Diabetes
- 5.3.2. Neurological Disorder
- 5.3.3. Smoking Cessation
- 5.3.4. Chronic Respiratory Disorders
- 5.3.5. Gastrointestinal Disorder
- 5.3.6. Cardiovascular Diseases
- 5.3.7. Medication Adherence
- 5.3.8. Rehabilitation & Patient Care
- 5.3.9. Others
5.4. Preventive Applications
- 5.4.1. Nutrition Management
- 5.4.2. Lifestyle Management
- 5.4.3. Other

6. Global Digital Therapeutic Market (by Sales Channel)

6.1. Overview
6.2. Growth Share Matrix
6.3. Business-to-Business (B2B)
- 6.3.1. Insurance Providers
- 6.3.2. Corporate Employers
- 6.3.3. Pharmaceutical Companies
- 6.3.4. Others
6.4. Business-to-Consumers
- 6.4.1. Patients
- 6.4.2. Caregivers

7. Global Digital Therapeutic Market (by Region)

7.1. Overview
7.2. North America
- 7.2.1. Key Findings
- 7.2.2. Market Size and Forecast
  - 7.2.2.1. North America Digital Therapeutics Market, by Product
  - 7.2.2.2. North America Digital Therapeutics Market, by Application
  - 7.2.2.3. North America Digital Therapeutics Market, by Sales Channel
  - 7.2.2.4. North America Digital Therapeutics Market, by Country
    - 7.2.2.4.1. U.S
    - 7.2.2.4.2. Canada
7.3. Europe
- 7.3.1. Key Findings
- 7.3.2. Market Size and Forecast
  - 7.3.2.1. Europe Digital Therapeutics Market, by Product
  - 7.3.2.2. Europe Digital Therapeutics Market, by Application
  - 7.3.2.3. Europe Digital Therapeutics Market, by Sales Channel
  - 7.3.2.4. Europe Digital Therapeutics Market, by Country
    - 7.3.2.4.1. U.K.
    - 7.3.2.4.2. Germany
    - 7.3.2.4.3. France
    - 7.3.2.4.4. Italy
    - 7.3.2.4.5. Spain
    - 7.3.2.4.6. Rest-of-Europe
7.4. Latin America
- 7.4.1. Key Findings
- 7.4.2. Market Size and Forecast
  - 7.4.2.1. Latin America Digital Therapeutics Market, by Product
  - 7.4.2.2. Latin America Digital Therapeutics Market, by Application
  - 7.4.2.3. Latin America Digital Therapeutics Market, by Sales Channel
  - 7.4.2.4. Latin America Digital Therapeutics Market, by Country
    - 7.4.2.4.1. Brazil
    - 7.4.2.4.2. Mexico
    - 7.4.2.4.3. Rest-of-Latin America
7.5. Asia-Pacific
- 7.5.1. Key Findings
- 7.5.2. Market Size and Forecast
  - 7.5.2.1. Asia-Pacific Digital Therapeutics Market, by Product
  - 7.5.2.2. Asia-Pacific Digital Therapeutics Market, by Application
  - 7.5.2.3. Asia-Pacific Digital Therapeutics Market, by Sales Channel
  - 7.5.2.4. Asia-Pacific Digital Therapeutics Market, by Country
    - 7.5.2.4.1. China
    - 7.5.2.4.2. Japan
    - 7.5.2.4.3. India
    - 7.5.2.4.4. Australia
    - 7.5.2.4.5. South Korea
    - 7.5.2.4.6. Rest-of-Asia-Pacific
7.6. Middle East and Africa
- 7.6.1. Key Findings
- 7.6.2. Market Size and Forecast
  - 7.6.2.1. Middle East and Africa Digital Therapeutics Market, by Product
  - 7.6.2.2. Middle East and Africa Digital Therapeutics Market, by Application
  - 7.6.2.3. Middle East and Africa Digital Therapeutics Market, by Sales Channel
  - 7.6.2.4. Middle East and Africa Digital Therapeutics Market, by Country
    - 7.6.2.4.1. K.S.A
    - 7.6.2.4.2. U.A.E.
    - 7.6.2.4.3. Israel
    - 7.6.2.4.4. South Africa
    - 7.6.2.4.5. Rest-of-Middle East and Africa

8. Global Digital Therapeutic Market: Competitive Insights and Company Profile

8.1. Overview
8.2. Key Strategies and Developments
- 8.2.1. Synergistic Activities
- 8.2.2. Regulatory Accreditations
- 8.2.3. Product and Service Launches
- 8.2.4. Acquisitions and Mergers
- 8.2.5. Approvals
8.3. Market Share Analysis
8.4. Global Ecosystem Glimpse
8.5. Company Profiles
- 8.5.1. Akili Interactive Labs, Inc.
  - 8.5.1.1. Company Overview
  - 8.5.1.2. Product Portfolio
  - 8.5.1.3. Recent Developments
  - 8.5.1.4. Analyst Perceptive
- 8.5.2. Kaia Health
- 8.5.3. 2MORROW, Inc.
- 8.5.4. Click Therapeutics, Inc.
- 8.5.5. Biofourmis Inc
- 8.5.6. Glooko, Inc.
- 8.5.7. CureApp
- 8.5.8. Kaia Health Software GmbH
- 8.5.9. HiDoc Technologies GmbH (Cara Care)
- 8.5.10. Neurotrack
- 8.5.11. Lark Health
- 8.5.12. Omada Health, Inc.
- 8.5.13. ResMed
- 8.5.14. Vida Health
- 8.5.15. Vivante Health, Inc.